Cargando…
Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study
BACKGROUND: Many studies have focused on multidrug therapy (MDT) for multibacillary (MB) leprosy and rarely on long-term outcome of paucibacillary (PB) leprosy having recommendation of therapy for 6 months fixed duration therapy for PB patients. Studies on measuring risk of disability are rare. The...
Autores principales: | Kumar, Anil, Girdhar, Anita, Girdhar, Bhavneswar Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425897/ https://www.ncbi.nlm.nih.gov/pubmed/22893667 http://dx.doi.org/10.1136/bmjopen-2012-001403 |
Ejemplares similares
-
Risk of developing disability in pre and post-multidrug therapy treatment among multibacillary leprosy: Agra MB Cohort study
por: Kumar, Anil, et al.
Publicado: (2012) -
Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study
por: Kumar, Anil, et al.
Publicado: (2013) -
WHO Multidrug Therapy for Leprosy: Epidemiology of Default in Treatment in Agra District, Uttar Pradesh, India
por: Kumar, Anil, et al.
Publicado: (2015) -
Altered cytokine profiles in relapsed paucibacillary leprosy: a case report
por: Sameshima, Tomoyuki, et al.
Publicado: (2021) -
Morphea Simulating Paucibacillary Leprosy Clinically and Histopathologically
por: Delgado, José Saulo Torres, et al.
Publicado: (2013)